Avanos Medical Inc. (8HH)
XDUS
21.60
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
21.6021.60
52 wk Range
8.2021.80
Financial Statements - 8HH - Avanos Medical Inc.
Revenue
701.20M▲ 20.4%
Net Income
-72.90M▲ 78.1%Net Margin -10.4%
EBITDA
57.50M▼ 25.5%
Free Cash Flow
43.10M▼ 38.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 701.20M | 582.60M | 673.30M | 684.10M | 587M | 714.80M |
| Cost of Goods | 347.30M | 259.62M | 293.60M | 289.90M | 287.80M | 341.50M |
| Gross Profit | 353.90M | 322.98M | 379.70M | 394.20M | 299.20M | 373.30M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 15.40M | 34.30M | 4.20M | 35.50M | -39M | -46.10M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -77M | -369.91M | - | - | - | - |
| Pre Tax Income | -66.20M | -341.61M | -7.90M | 26.70M | -42.10M | -60.50M |
| Income Tax | 6.70M | -14.40M | 2M | 5.20M | -11.20M | -33.30M |
| Net Income | -72.90M | -332.13M | -61.80M | 50.50M | 6.30M | -27.20M |
| EPS Basic | - | -8.53 | -1.32 | 1.08 | 0.11 | -0.57 |
| EPS Diluted | - | -8.53 | -1.32 | 1.07 | 0.11 | -0.57 |
| Basic Shares Outstanding | - | 38.96M | 48.49M | 48.80M | 50.05M | 49.74M |
| Diluted Shares Outstanding | - | 38.96M | 48.49M | 48.80M | 50.05M | 49.74M |
| Ebit | -58.40M | -331.28M | 7.10M | 36.70M | -38.80M | -44.90M |
| Ebitda | 57.50M | 77.16M | 53.20M | 84.40M | -500K | -2M |
| Net Income Continuous Operations | -72.90M | -332.13M | -61.80M | 50.50M | 6.30M | -27.20M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
